Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.
The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently upregulated in several types of tumors and enhances hematogenous metastasis by interacting with and activating the platelet receptor CLEC-2. Thus, Aggrus-CLEC-2 binding could be a therapeutic molecular mechanism...
Saved in:
Main Authors: | Satoshi Takagi, Shigeo Sato, Tomoko Oh-hara, Miho Takami, Sumie Koike, Yuji Mishima, Kiyohiko Hatake, Naoya Fujita |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/371badaf6d0b449ca1ff7fa393a4d7f9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The podoplanin-CLEC-2 axis inhibits inflammation in sepsis
by: Julie Rayes, et al.
Published: (2017) -
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
by: Kenichi Miyata, et al.
Published: (2017) -
Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2
by: Pei-Shan Sung, et al.
Published: (2019) -
Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity
by: Tomofumi Uto, et al.
Published: (2016) -
The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure
by: Abhishek Chauhan, et al.
Published: (2020)